Bevorin 200mg Capsule SR

Introduction

Bevorin is a prescription medication that contains the active ingredient Mebeverine. It is available in the form of extended-release capsules.

Uses

Bevorin is primarily prescribed to relieve symptoms associated with irritable bowel syndrome (IBS) and other conditions involving intestinal spasms. It helps to reduce abdominal pain, cramping, bloating, and discomfort caused by these conditions.

Dosage and Administration

The recommended dosage of Bevorin may vary depending on the individual’s condition and response to treatment. It is typically taken orally, usually once or twice a day, with a glass of water. Follow the instructions provided by your healthcare provider. Do not crush or chew the capsules, as they are formulated for extended-release.

Mechanism of Action

Mebeverine, the active ingredient in Bevorin, works by relaxing the smooth muscles in the walls of the intestines. This helps to reduce spasms and normalize the contractions of the digestive system, thereby relieving the associated symptoms of IBS and intestinal spasms.

Side Effects

Common side effects may include mild gastrointestinal symptoms such as nausea, diarrhea, or constipation. If these side effects persist or worsen, consult your healthcare provider. Serious side effects are rare, but if you experience any severe abdominal pain, difficulty breathing, or signs of an allergic reaction (such as rash, itching, or swelling), seek immediate medical attention.

Drug Interactions

Bevorin may interact with certain medications, including anticholinergic drugs, which can reduce its effectiveness or increase the risk of side effects. Inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements, to avoid potential interactions.

Precautions

Before taking Bevorin, inform your healthcare provider about any existing medical conditions or allergies you may have. Additionally, let your healthcare provider know about all the medications you are currently taking to ensure the safe and effective use of this medication. Bevorin should not be used in individuals with a known hypersensitivity to Mebeverine or any other ingredients in the formulation.

Storage

Bevorin should be stored at room temperature, away from moisture and direct sunlight. Keep the medication out of reach of children and pets. Do not use the medication after the expiration date printed on the packaging. If you have any unused or expired medication, consult your pharmacist or healthcare provider for proper disposal methods.

Patient Tips

Here are a few tips to help you get the most benefit from Bevorin:

• Take the medication as prescribed by your healthcare provider.
• If you forget to take a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not double the dose to make up for a missed one.
• If you have any concerns or questions about the medication, do not hesitate to reach out to your healthcare provider or pharmacist.
• Maintain a healthy lifestyle by incorporating a balanced diet, regular exercise, and stress management techniques, as these factors may help reduce the symptoms associated with irritable bowel syndrome.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Mebeverine: a medicine to treat muscle spasms (NHS UK) [Accessed 5 Jun. 2024] (online) Available at:
• Aurobeverine MR 200mg modified-release capsules, hard (Health Professionals SmPC) Available at:
• MEBEVERINE HYDROCHLORIDE 135MG TABLETS (Drugs.com) [Accessed 20 Jun. 2024] (online) Available at:
• Medications for IBS (International Foundation for Gastrointestinal Disorders) [Accessed 16 Jun. 2024] (online) Available at:
• Daniluk J, Malecka-Wojciesko E, Skrzydlo-Radomanska B, Rydzewska G. The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome-A Systematic Review. J Clin Med. 2022 Feb 17;11(4):1044. doi: 10.3390/jcm11041044. [Accessed 19 Jun. 2024] Available at: